NON-CYSTIC FIBROSIS BRONCHIECTASIS
Clinical trials for NON-CYSTIC FIBROSIS BRONCHIECTASIS explained in plain language.
Never miss a new study
Get alerted when new NON-CYSTIC FIBROSIS BRONCHIECTASIS trials appear
Sign up with your email to follow new studies for NON-CYSTIC FIBROSIS BRONCHIECTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cystic fibrosis drug tested for similar lung condition
Disease control CompletedThis study tested whether Trikafta, a drug approved for cystic fibrosis, could help people with non-cystic fibrosis bronchiectasis (NCFBE), a different lung condition with similar symptoms. Thirty-two adults with NCFBE took Trikafta for four weeks while researchers measured their…
Matched conditions: NON-CYSTIC FIBROSIS BRONCHIECTASIS
Phase: PHASE4 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 02, 2026 01:10 UTC
-
New drug shows promise in reducing dangerous lung infections
Disease control CompletedThis large Phase 3 trial tested whether a daily pill called brensocatib could reduce the frequency of serious lung flare-ups in people with bronchiectasis, a chronic lung condition. Over 1,700 participants took either the drug or a placebo for one year to see if it lowered their …
Matched conditions: NON-CYSTIC FIBROSIS BRONCHIECTASIS
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Virus vs. superbug: inhaled phage therapy fights stubborn lung infection
Disease control CompletedThis study tested whether inhaling a special virus mixture (called AP-PA02) could safely reduce a hard-to-treat bacteria in the lungs of people with bronchiectasis. It involved 48 adults with a chronic Pseudomonas aeruginosa infection. Participants were randomly assigned to recei…
Matched conditions: NON-CYSTIC FIBROSIS BRONCHIECTASIS
Phase: PHASE2 • Sponsor: Armata Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC